Publications:  Prof Ranjit Manchanda

Gaba F, Blyuss O, Liu X, Goyal S, Lahoti N, Chandrasekaran D, Kurzer M, Kalsi J et al.(2020). Population study of ovarian cancer risk prediction for targeted screening and prevention. Cancers vol. 12, (5)

Evans O, Manchanda R(2020). Population-based Genetic Testing for Precision Prevention. Cancer Prev Res (Phila)

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.(2020). Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448] (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679)). Gynecologic Oncology vol. 157, (2) 558-559.

Manchanda R, Buist DSM, Evans DGR(2020). Future Research Suggestions for Multigene Testing in Unselected Populations-Reply. JAMA Oncology vol. 6, (5) 785-786.

Evans O, Gaba F, Manchanda R(2020). Population-based genetic testing for Women's cancer prevention. Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 65, 139-153.

Gaba F, Manchanda R(2020). Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers. Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 65, 46-65.

Manchanda R, Lieberman S, Gaba F, Lahad A, Levy-Lahad E(2020). Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. Annual Review of Genomics and Human Genetics vol. 21, (1) Article annurev-genom-083118,

Manchanda R(2020). Advances in the screening and prevention of Women's cancers. Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 65, 1-2.

Casey L, Powell A, Bohm S, Manchanda R, Lockley M, Kobel M, Singh N (2020). Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy. MODERN PATHOLOGY. vol. 33, 1024-1024.

Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al.(2020). Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. BJOG: An International Journal of Obstetrics and Gynaecology vol. 127, (3) 364-375.

Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I et al.(2019). Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results. Histopathology vol. 75, (6) 813-824.

Daia MT, Chandrasekaran D, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A, Phadnis S (2019). FOLLOW THE YELLOW BRICK ROAD - SUPRA-RENAL PARA-AORTIC LYMPHADENECTOMY FOR METASTATIC OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A665-A665.

Dokmeci AM, Abdurrayman M, Drymiotou S, Chandrasekaran D, Rai N, Dilley J, Phadnis S, Manchanda R et al. (2019). HAS THE ROBOT BEEN BENEFICIAL TO ENDOMETRIAL CANCER PATIENTS? A PROSPECTIVE QUALITY IMPROVEMENT PROJECT AT A LONDON GYNAE-ONCOLOGY TERTIARY CENTRE. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A315-A315.

Gaba F, Liu X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Menon U, Jacobs I et al. (2019). IMPACT OF POPULATION GENETIC TESTING AND OVARIAN CANCER RISK STRATIFICATION ON THE EMOTIONAL WELL-BEING AND HEALTH OF UNSELECTED WOMEN IN A GENERAL POPULATION. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A53-A53.

Gaba F, Chandrasekaran D, Menon U, Evans G, Singh N, McCluggage G, Wilkinson N, Ganesan R et al. (2019). PREVENTING OVARIAN CANCER THROUGH EARLY EXCISION OF TUBES AND LATE OVARIAN REMOVAL (PROTECTOR) STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A52-A52.

Sundar S, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al. (2019). QUALITY OF LIFE AFTER SURGERY OF VARYING SURGICAL COMPLEXITY IN ADVANCED OVARIAN CANCER: RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER COHORT SOCQER2 STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A638-A639.

Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al. (2019). RANDOMISED TRIAL OF UNSELECTED BRCA TESTING IN ASHKENAZI JEWS: LONG TERM OUTCOMES AND FACTORS AFFECTING UPTAKE OF TESTING. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A13-A13.

Drymiotou S, Dokmeci AM, Chandrasekaran D, Dilley J, Rai N, Lawrence A, Manchanda R, Phadnis S et al. (2019). ROBOTIC SURGERY: DOES HIGH BODY MASS INDEX (BMI) MATTER?. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A316-A316.

Sun L, Brentnall A, Patel S, Buist D, Bowles E, Evans DG, Eccles D, Hopper J et al. (2019). SHOULD WE OFFER MULTI-GENE TESTING TO ALL PATIENTS WITH BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A31-A32.

Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.(2019). A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer. JAMA Oncology

Sun L, Brentnall A, Patel S, Buist SM D, Bowles JA E, Evans R DG, Eccles D, Hopper J et al.(2019). 66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. Regional plenary

Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al. (2019). ATTITUDE TOWARDS AND FACTORS AFFECTING UPTAKE OF POPULATION BASED BRCA TESTING IN ASHKENAZI JEWS: A COHORT STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A42-A43.

Manchanda R, Sun L, Patel S, Wilschut J, Lopes Carolina de Freitas A, Brentnall A, Duffy S, Cui B et al. (2019). GLOBAL ECONOMIC EVALUATION OF POPULATION-BASED BRCA1/BRCA2 MUTATION TESTING. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 29, A6-A7.

Tan A, Rivas C, Yorke S, Khan K, Rogozinska E, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG: an International Journal of Obstetrics and Gynaecology. Conference: RCOG World Congress 2019 vol. 126, 85-85.

Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 82-82.

Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 84-84.

Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N (2019). Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. vol. 126, 86-87.

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.(2019). Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. Gynecologic Oncology

Crosbie E, MANCHANDA R, Manchester International Consensus Group(2019). The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genetics in Medicine

GABA F, Piek J, Menon U, MANCHANDA R(2019). Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary. BJOG: An International Journal of Obstetrics and Gynaecology

MANCHANDA R, GABA F(2019). A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm. BJOG: An International Journal of Obstetrics and Gynaecology

Koutoukidis D, Beeken R, MANCHANDA R, Burnell M, Ziauddeen N, Michalopoulou M, Knobf MT, Lanceley A(2019). Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial. International Journal of Gynecological Cancer vol. 29, (3)

MANCHANDA R, Matthew B, GABA F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al.(2019). Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology

Osman M, Chandrasekaran D, Musa E, Afnan-Holmes H, Brockbank E, Lawrence A, Manchanda R (2018). Evaluation of the diagnostic hysteroscopy service in gynaecology oncology. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. Conference: National Trainees Conference 2018 vol. 125, 24-24.

MANCHANDA R, GABA F(2018). Population Based Testing for Primary Prevention: A Systematic Review. Cancers

Puntambekar S, MANCHANDA R(2018). Surgical pelvic anatomy in gynecologic oncology. International Journal of Gynecology and Obstetrics vol. 143, 86-92.

MANCHANDA R, Legood R(2018). Population based germline testing for primary cancer prevention. Oncotarget vol. 9, (69) 33062-33063.

Jiang J, Phadnis S, Miller R, Powell M, Sahdev A, Singh N, Lawrence A, Brockbank E et al. (2018). DISTANT RECURRENCES ARE COMMON FOLLOWING PELVIC EXENTERATION FOR MALIGNANCY OF NON-CERVICAL ORIGIN. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 28, 963-963.

Jiang J, Phadnis S, Miller R, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A (2018). OUTCOMES OF BOWEL RESECTIONS DURING SURGICAL CYTOREDUCTION OF ADVANCED STAGE OVARIAN CANCER: SHOULD WE BE WORKING TOWARDS REDUCING STOMA RATES?. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 28, 719-719.

Singh N, Piskorz A, Bosse T, Jimenez-Linan M, Jeyarajah A, Manchanda R, Gilks CB, Brenton J et al. (2018). P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 28, 565-565.

Sundar S, Kumar S, Long J, Balega J, Fotopoulou C, Broadhead T, Duncan T, Morrison J et al. (2018). PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 28, 604-606.

Farrag A, Light M, Sahdev A, Singh N, Brockbank E, Manchanda R, Phadnis S (2018). SOLITARY RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE CERVIX IN THE OMENTUM - MANAGEMENT OF AN UNUSUAL PRESENTATION. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 28, 366-366.

Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Gan C, Taylor R et al.(2018). Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. Journal of Medical Genetics vol. 55, (8) 538-545.

Yang X, Leslie G, Gentry-Maharaj A, Ryan A, Intermaggio M, Lee A, Kalsi JK, Tyrer J et al.(2018). Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. Journal of Medical Genetics vol. 55, (8) 546-554.

Vazquez MA, Marino IP, BLYUSS O, Ryan A, GENTRY-MAHARAJ A, Kalsi J, MANCHANDA R, Jacobs I et al.(2018). A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer. Biomedical Signal Processing and Control

Cohen P, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.(2018). Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data.

BLYUSS O, Burnell M, Ryan A, GENTRY-MAHARAJ A, Marino I, Kalsi J, MANCHANDA R, Timms JF et al.(2018). Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population. Clinical Cancer Research

Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ et al.(2018). Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. Gynecologic Oncology Reports

Crusz SM, Chandrasekaran D, Phadnis S, Delvin MJ, Quigley M, Powell ME (2018). Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC). JOURNAL OF CLINICAL ONCOLOGY. vol. 36,

Chandrasekaran D, Manchanda R(2018). Germline & somatic genetic testing in ovarian cancer patients. BJOG

Patel S, Legood R, Evans DG, Turnbull C, Antoniou AC, Menon U, Jacobs I, Manchanda R(2018). Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women. American Journal of Obstetrics and Gynecology vol. 218, (4) 431.e1-431.e12.

Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ et al.(2018). Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. Journal of the National Cancer Institute vol. 110, (7) 714-725.

MANCHANDA R, Menon U(2017). Setting the threshold for surgical prevention in women at increased risk of ovarian cancer. International Journal of Gynecological Cancer

Meisel SF, Freeman M, Waller J, Fraser L, Gessler S, Jacobs I, Kalsi J, Rahman B et al.(2017). Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study. BMC Public Health vol. 17, Article 882,

Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ et al.(2017). Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry. American Journal of Obstetrics and Gynecology vol. 217, (5) 578.e1-578.e12.

Manchanda R, Gaba F, Bottla K, Mousa K, Burnell M, Kalsi J, Gentry-Maharaj A, Antoniou A et al. (2017). PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 27, 1944-1944.

Koutoukidis DA, Beeken RJ, Manchanda R, Michalopoulou M, Burnell M, Knobf MT, Lanceley A(2017). Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial. BMJ Open vol. 7, (10)

Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR et al.(2017). Persistence of fimbrial tissue on the ovarian surface after salpingectomy. American Journal of Obstetrics and Gynecology vol. 217, (4) 425.e1-425.e16.

Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.(2017). Evidence of Stage Shift in Women Diagnosed with Ovarian Cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. Obstetrical and Gynecological Survey vol. 72, (6) 338-340.

MANCHANDA R, Legood R, Antoniou AC, Pearce L, Menon U(2017). Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer. BJOG: An International Journal of Obstetrics and Gynaecology

Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.(2017). Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. J Clin Oncol vol. 35, (13) 1411-1420.

Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L(2017). Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges. Gynecologic Oncology Reports vol. 20, 9-14.

Manchanda R(2017). Opportunistic salpingectomy for prevention of ovarian cancer. BJOG: An International Journal of Obstetrics and Gynaecology vol. 124, (6) 890-890.

Gan C, Bossart M, Piek J, Halaska M, Haidopoulos D, Zapardiel I, Grabowski JP, Kesic V et al.(2017). Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees. International Journal of Gynecological Cancer vol. 27, (2) 375-381.

Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A(2017). Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1. Trials vol. 18, (1) 28-28.

Gaba FM, Manchanda R, Gaba FM, Manchanda R(2017). Genetic testing for gynaecological cancer. Obstetrics, Gynaecology and Reproductive Medicine vol. 27, (1) 29-31.

Burnell M, Iyer R, Gentry-Maharaj A, Nordin A, Liston R, Manchanda R, Das N, Gornall R et al.(2016). Benchmarking of surgical complications in gynaecological oncology: Prospective multicentre study. BJOG: An International Journal of Obstetrics and Gynaecology vol. 123, (13) 2171-2180.

Pennington M, Gentry-Maharaj A, Karpinskyj C, Miners A, Taylor J, Manchanda R, Iyer R, Griffin M et al.(2016). Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). PLoS One vol. 11, (11) Article 0165539, e0165539-e0165539.

La Russa M, Biliatis I, Brockbank E, Faruki A, Lawrence A, Manchanda R, Singh N, Jeyarajah A (2016). CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting (Lisbon, Portugal) from: 29/10/2016 to: 31/10/2016, vol. 26, 1013-1013.

Manchanda R, Gordeev V, Antoniou A, Smith S, Lee A, Hopper J, Macinnis R, Paul P et al. (2016). Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016) vol. 26, 59-60.

Phadnis S, Vali S, Oram D, Lawrence A, Manchanda R, Jeyarajah A, Brockbank E (2016). Enhanced recovery after major gynaecological oncology surgery: Are we meeting the standards?. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 26, 924-924.

Phadnis S, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E (2016). Morbidity and mortality following major surgery for gynaecological malignancy: A prospective observational study from a cancer centre in London. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 26, 925-925.

Kumar S, Long J, Rudge G, Manchanda R, Fotopoulou C, Wood N, Duncan T, Balega J et al. (2016). SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal (Lisbon, Portugal) from: 29/10/2016 to: 31/10/2016, vol. 26, 832-833.

Phadnis S, Korompelis P, Iamprou C, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E (2016). Surgical and oncological outcome of morbidly obese (BMI > 40) women having laparoscopic surgery for early stage endometrial cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 26, 1057-1057.

Manchanda R, Legood R, Antoniou AC, Gordeev VS, Menon U(2016). Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingooophorectomy' for ovarian cancer prevention: A cost-effectiveness analysis. Journal of Medical Genetics vol. 53, (9) 591-599.

Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L et al.(2016). Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations. Journal of Medical Genetics vol. 53, (7) 472-480.

Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens AL, Cibula D, Bookman MA et al.(2016). Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. International Journal of Gynecological Cancer vol. 26, (6) 1186-1188.

Manchanda R, Cibula D(2016). Ovarian Cancer Screening There May Be Light at the End of the Tunnel?. Int J Gynecol Cancer vol. 26, (4) 608-609.

Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A(2016). Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. Trials vol. 17, (1)

MANCHANDA R, Menon U(2016). Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial FOR: There is lack of clarity on a number of key issues. BJOG: an International Journal of Obstetrics and Gynaecology vol. 123, (3) 463-463.

Manchanda R, Jacobs I(2016). Genetic screening for gynecological cancer: Where are we heading?. Future Oncology vol. 12, (2) 207-220.

Manchanda R, Chandrasekaran D, Saridogan E, Burnell M, Crawford R, Brockbank E, Kalsi J, Jurkovic D et al.(2016). Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated into Routine Care or Offered in the Context of a Clinical Trial?. International Journal of Gynecological Cancer vol. 26, (1) 31-33.

Blyuss KB, MANCHANDA R, Kurths J, Alsaedi A, Zaikin A(2016). Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks. Computational and Mathematical Methods in Medicine vol. 2016, Article 7904693,

Dilley J, Manchanda R, Johnson M, Rosenthal AN, Gessler S, Menon U(2015). Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients. International Journal of Gynecology & Obstetrics vol. 133, (2) 239-240.

Manchanda R, Legood R, Pearce L, Menon U(2015). Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. Gynecologic Oncology vol. 139, (3) 487-494.

Manchanda R, Loggenberg K, Burnell M, Wardle J, Sanderson S, Gessler S, Side L, Balogun N et al. (2015). A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. vol. 25, 48-49.

Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.(2015). Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Familial Cancer vol. 14, (4) 521-530.

Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.(2015). Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Familial Cancer

Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF et al.(2015). A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. Journal of Medical Genetics vol. 52, (7) 465-475.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S et al.(2015). Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. Journal of the National Cancer Institute vol. 107, (1)

Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al.(2015). Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial. Journal of the National Cancer Institute vol. 107, (1)

Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R et al.(2015). Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC - UK gynaecological oncology surgical outcomes and complications). British Journal of Cancer vol. 112, (3) 475-484.

Piek J, Bossart M, Boor K, Halaska M, Haidopoulos D, Zapardiel I, Grabowski J, Kesic V et al.(2015). The work place educational climate in gynecological oncology fellowships across Europe the impact of accreditation. International Journal of Gynecological Cancer vol. 25, (1) 180-190.

Manchanda R, Legood R, Burnell M, McGuire A, Loggenberg K, Wardle J, Sanderson S, Gessler S et al.(2014). POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 24, (9) 470-471.

Philpott S, Rizzuto I, Fraser L, Manchanda R, Hadwin R, Burnell M, Mackay S, Skates S et al.(2013). DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23, (8)

Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al.(2013). RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23, (8)

Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, Gultekin M, Vranes B et al.(2013). The need for more workshops in laparoscopic surgery and surgical anatomy for european gynaecological oncology trainees: A survey by the european network of young gynaecological oncologists. International Journal of Gynecological Cancer vol. 23, (6) 1126-1131.

Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). JOURNAL OF CLINICAL ONCOLOGY. vol. 31,

Manchanda R, Godfrey M, Wong-Taylor LA, Halaska MJ, Burnell M, Grabowski JP, Gultekin M, Haidopoulos D et al.(2013). The need for accredited training in gynaecological oncology: A report from the european network of young gynaecological oncologists (ENYGO). Annals of Oncology vol. 24, (4) 944-952.

Kalsi JK, Manchanda R, Menon U(2013). Screening for gynecological cancers. Expert Review of Obstetrics and Gynecology vol. 8, (2) 143-160.

Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH et al.(2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. Journal of Clinical Oncology vol. 31, (1) 49-57.

Manchanda R, Drapkin R, Menon U(2013). There is a need for routine peritoneal cytology at RRSO. Gynecologic Oncology vol. 128, (1) 149-150.

Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Side L et al.(2012). Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). Archives of Gynecology and Obstetrics vol. 286, (6) 1555-1562.

Fourkala EO, Gentry-Maharaj A, Burnell M, Ryan A, Manchanda R, Dawnay A, Jacobs I, Widschwendter M et al.(2012). Histological confirmation of breast cancer registration and self-reporting in England and Wales: A cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. British Journal of Cancer vol. 106, (12) 1910-1916.

Manchanda R, Silvanto A, Abdelraheim A, Burnell M, Johnson M, Saridogan E, Rosenthal AN, Brunell C et al.(2012). Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy. International Journal of Gynecological Cancer vol. 22, (5) 881-888.

Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A(2012). International conference on ovarian cancer screening 29th-30th November 2011, Royal College of Physicians, London. International Journal of Gynecological Cancer vol. 22, (SUPPL. 1)

Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E et al.(2012). Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis. BJOG: An International Journal of Obstetrics and Gynaecology vol. 119, (5) 527-536.

Gentry-Maharaj A, Kalsi J, Burnell M, Manchanda R, Menon U(2012). Screening of symptomatic women for ovarian cancer. The Lancet Oncology vol. 13, (4)

Vaes E, Manchanda R, Autier P, Nir R, Nir D, Bleiberg H, Robert A, Menon U(2012). Differential diagnosis of adnexal masses: Sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool. Ultrasound in Obstetrics and Gynecology vol. 39, (1) 91-98.

Brantnerova R, Manchanda R, Colombo N(2012). The European society of gynaecological oncology: update on objectives and educational and research activities. Am Soc Clin Oncol Educ Book335-338.

Manchanda R, Drapkin R, Jacobs I, Menon U(2012). The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecologic Oncology vol. 124, (2) 185-191.

Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JMJ, Manchanda R et al.(2011). Gynecologic oncology training systems in Europe: A report from the European network of young gynaecological oncologists. International Journal of Gynecological Cancer vol. 21, (8) 1500-1506.

Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L et al.(2011). Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG: An International Journal of Obstetrics and Gynaecology vol. 118, (7) 814-824.

Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Autier P, Menon U, Robert A(2011). Mathematical models to discriminate between benign and malignant adnexal masses: Potential diagnostic improvement using ovarian histoscanning. International Journal of Gynecological Cancer vol. 21, (1) 35-43.

Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW et al.(2011). Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort. The Lancet Oncology vol. 12, (1) 38-48.

Pichert G, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al.(2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Familial Cancer vol. 9, (3) 313-319.

Manchanda R, Rosenthal A, Burnell M, Fraser L, Mackay J, Skates S(2009). Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers. Journal of Medical Genetics vol. 46, (6) 423-424.

Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I(2009). Hereditary non-polyposis colorectal cancer or Lynch syndrome: The gynaecological perspective. Current Opinion in Obstetrics and Gynecology vol. 21, (1) 31-38.

Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J, Welton K, Shafi M(2009). Is close follow up feasible for high-risk cervical premalignant lesion in developing countries? Author's reply. BJOG: An International Journal of Obstetrics and Gynaecology vol. 116, (1) 125-126.

Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J, Welton K, Shafi M(2008). Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG: An International Journal of Obstetrics and Gynaecology vol. 115, (10) 1238-1242.

Manchanda R, Palep-Singh M, Prentice A(2008). Can uterine artery embolisation affect endometrial perfusion and function. Journal of Obstetrics and Gynaecology vol. 28, (2) 246-248.

Manchanda R, Kriplani A(2005). Giant malignant ovarian tumor: A case report. International Journal of Gynecological Cancer vol. 15, (6) 1135-1137.

Manchanda R, Sriemevan A(2005). Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta. Journal of Obstetrics and Gynaecology vol. 25, (2) 201-202.

Manchanda R, Refaie A(2005). Acute pneumoperitoneum following coitus. CJEM vol. 7, (1) 51-53.

Manchanda R, Varma R, Anya I, Ting JYS(2004). Representation of authors and editors from poor countries [1] (multiple letters). British Medical Journal vol. 329, (7457) 110-111.

Manchanda R, Varma R(2004). Representation of authors and editors from poor countries: observed publication bias may reflect who is funding research. BMJ (Clinical research ed.) vol. 329, (7457)

Kriplani A, Agarwal N, Parul, Sharma MC, Manchanda R(2003). Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis. Journal of Obstetrics and Gynaecology Research vol. 29, (2) 63-66.

Kriplani A, Manchanda R, Nath J, Takkar D(2002). A randomized trial of danazol pretreatment prior to endometrial resection. European Journal of Obstetrics and Gynecology and Reproductive Biology vol. 103, (1) 68-71.

Kriplani A, Manchanda R, Monga D, Takkar D(2001). Depot medroxy progesterone acetate: A poor preparatory agent for endometrial resection. Gynecologic and Obstetric Investigation vol. 52, (3) 180-183.

Kriplani A, Agarwal N, Roy KK, Manchanda R, Singh MK(2001). Laparoscopic management of Sertoli-Leydig cell tumors of the ovary: A report of two cases. Journal of Reproductive Medicine for the Obstetrician and Gynecologist vol. 46, (5) 493-496.

Kriplani A, Manchanda R, Agarwal N, Nayar B(2001). Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. Journal of the American Association of Gynecologic Laparoscopists vol. 8, (4) 511-518.